Divi's Laboratories has reported results for first quarter ended June 30, 2022.
The company has reported a rise of 25.30% in its net profit at Rs 691.61 crore for the quarter under review as compared to Rs 551.97 crore for the same quarter in the previous year. Total income of the company increased by 15.52% at Rs 2293.91 crore for Q1FY23 as compared Rs 1985.71 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 26.01% in its net profit at Rs 702.01 crore for the quarter under review as compared to Rs 557.11 crore for the same quarter in the previous year. Total income of the company increased by 17.34% at Rs 2342.91 crore for Q1FY23 as compared Rs 1996.61 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1531.35 |
Dr. Reddys Lab | 6057.30 |
Cipla | 1369.70 |
Zydus Lifesciences | 936.40 |
Lupin | 1619.75 |
View more.. |